# McEwen Inc.: overview

MUX · NYSE · CIK 314203 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mux.md) · [Financials](/companies/mux/financials.md) · [Filings](/companies/mux/filings.md) · [Insiders](/companies/mux/insiders.md)

Latest reported revenue: [$59.2m](/filings/0001104659-26-091284.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-091284).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [52.3](/filings/0001104659-26-028705.md) | [33.5](/filings/0001104659-26-028705.md) | [35.7](/filings/0001104659-26-056349.md) | [46.7](/filings/0001104659-26-091284.md) | [50.5](/filings/0001104659-26-028705.md) | [64.6](/filings/0001104659-26-028705.md) | [74.0](/filings/0001104659-26-056349.md) | [59.2](/filings/0001104659-26-091284.md) |
| Gross margin | % | [26.4%](/filings/0001104659-26-028705.md) | [1.1%](/filings/0001104659-26-028705.md) | [28.2%](/filings/0001104659-26-056349.md) | [26.3%](/filings/0001104659-26-091284.md) | [15.5%](/filings/0001104659-26-028705.md) | [26.9%](/filings/0001104659-26-028705.md) | [42.5%](/filings/0001104659-26-056349.md) | [33.9%](/filings/0001104659-26-091284.md) |
| Operating margin | % | [(0.2%)](/filings/0001104659-25-107117.md) | [(43.4%) d](/filings/0001104659-26-028705.md) | [(21.4%)](/filings/0001104659-26-056349.md) | [(7.2%)](/filings/0001104659-26-091284.md) | [(16.7%)](/filings/0001104659-25-107117.md) | [34.2% d](/filings/0001104659-26-028705.md) | [55.7%](/filings/0001104659-26-056349.md) | [13.0%](/filings/0001104659-26-091284.md) |
| Net margin | % | [(4.0%)](/filings/0001104659-26-028705.md) | [(24.6%)](/filings/0001104659-26-028705.md) | [(17.6%)](/filings/0001104659-26-028705.md) | [6.5%](/filings/0001104659-26-091284.md) | [(0.9%)](/filings/0001104659-26-028705.md) | [59.0%](/filings/0001104659-26-028705.md) | [45.1%](/filings/0001104659-26-056349.md) | [16.2%](/filings/0001104659-26-091284.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001104659-26-028705.md) | [(0.16)](/filings/0001104659-26-028705.md) | [(0.12)](/filings/0001104659-26-056349.md) | [0.06](/filings/0001104659-26-091284.md) | [(0.01)](/filings/0001104659-26-028705.md) | [0.57](/filings/0001104659-26-028705.md) | [0.47](/filings/0001104659-26-056349.md) | [0.14](/filings/0001104659-26-091284.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [137](/filings/0001558370-24-003434.md) | [110](/filings/0001558370-25-003017.md) | [166](/filings/0001104659-26-028705.md) | [174](/filings/0001104659-26-028705.md) | [198](/filings/0001104659-26-028705.md) |
| Gross margin | % | [(4.7%)](/filings/0001558370-24-003434.md) | [(0.5%)](/filings/0001558370-25-003017.md) | [10.7%](/filings/0001104659-26-028705.md) | [17.7%](/filings/0001104659-26-028705.md) | [24.1%](/filings/0001104659-26-028705.md) |
| Operating margin | % | [(47.1%)](/filings/0001558370-24-003434.md) | [(86.4%)](/filings/0001558370-25-003017.md) | [(97.5%)](/filings/0001104659-26-028705.md) | [(29.0%)](/filings/0001104659-26-028705.md) | [1.3%](/filings/0001104659-26-028705.md) |
| Net margin | % | [(41.5%)](/filings/0001104659-24-054209.md) | [(73.4%)](/filings/0001558370-25-003017.md) | [33.3%](/filings/0001104659-26-028705.md) | [(25.0%)](/filings/0001104659-26-028705.md) | [(0.6%)](/filings/0001104659-26-056349.md) |
| Diluted EPS | $ per share | [(1.25)](/filings/0001558370-24-003434.md) | [(1.71)](/filings/0001558370-25-003017.md) | [1.16](/filings/0001104659-26-028705.md) | [(0.86)](/filings/0001104659-26-028705.md) | [0.59](/filings/0001104659-26-028705.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mux/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $86.1m | 4,746,836 |  | Added +2,798,408 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $77.1m | 4,254,551 |  | Added +891,024 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $37.2m | 2,054,059 |  | Reduced −79,750 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $27.5m | 1,519,282 |  | Reduced −49,675 |
| [Tidal Investments LLC](/funds/1600064.md) | 2026-06-30 | $26.8m | 1,478,168 |  | Added +117,791 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $26.0m | 1,435,094 |  | Added +832,050 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $24.7m | 1,365,177 |  | Added +95,417 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $18.5m | 1,023,116 |  | Reduced −280,522 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $16.0m | 883,013 |  | Added +196,543 |
| [BNP PARIBAS FINANCIAL MARKETS](/funds/1166588.md) | 2026-06-30 | $15.7m | 865,033 |  | Reduced −224,340 |

## Recent filings

[All 1,304 filings](/companies/mux/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:15 ET | [8-K](/filings/0001104659-26-115508.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115508 |
| 2026-09-01 | 20:14 ET | [8-K](/filings/0001104659-26-104311.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-104311 |
| 2026-08-26 | 21:10 ET | [8-K](/filings/0001104659-26-101630.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-101630 |
| 2026-08-07 | 20:15 ET | [8-K](/filings/0001104659-26-092719.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092719 |
| 2026-08-05 | 21:29 ET | [10-Q](/filings/0001104659-26-091284.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091284 |
| 2026-06-30 | 21:06 ET | [8-K](/filings/0001104659-26-079394.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-079394 |
| 2026-06-24 | 21:20 ET | [10-K/A](/filings/0001104659-26-077359.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-077359 |
| 2026-06-10 | 21:09 ET | [8-K](/filings/0001104659-26-072415.md) | 5.07 Shareholder vote results | 0001104659-26-072415 |
| 2026-06-02 | 20:45 ET | [8-K](/filings/0001104659-26-069531.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-069531 |
| 2026-06-01 | 21:14 ET | [8-K/A](/filings/0001104659-26-069016.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-069016 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-028705.md), filed Mar 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/97218333-c0ce-4d2f-95e2-2cb7950ae94b)

## About the filer

- CIK: 314203
- Tickers: MUX
- Exchange: NYSE
- SIC code: 1040 Gold and Silver Ores
- State of incorporation: CO
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.